Physalis angulata

Physalis angulata · Accepted scientific name

Scientific literature: Very Sparse (15 studies) · ★☆☆☆☆

Physalis angulata is a versatile medicinal plant known for its diverse pharmacological properties, including antiplasmodial, cytotoxic, and antioxidant activities. The plant contains a rich profile of bioactive chemicals such as withanolides, flavonoids, physalin, and chlorogenic acid. Various parts of the plant, including the leaves, fruits, flowers, and roots, are utilized to combat conditions like malaria, cancer, and diabetes. Researchers often utilize whole plants or crude extracts to harness these therapeutic benefits through various medicinal preparations. Consequently, this species remains a significant subject of study for its potential in developing new antimalarial and antidiabetic treatments.

Quick facts
Synonyms
Physalis Bodinieri · Physalis Ramosissima · 27 more
Common names
Not available
Family
Solanaceae
Distribution
Not available
Plant Parts
Leaf · Fruit

Classification

Common Names

Physalis angulata is a versatile plant known by a diverse array of regional and descriptive names. In many English-speaking areas, it is frequently referred to as the Angular Winter-cherry or the Lanceleaf Groundcherry. It also carries the common name Cutleaf Groundcherry, which highlights its distinct foliage. In German-speaking regions, the species is recognized as Kantige Blasenkirsche. Finally, it is identified in certain contexts by the name Pchfux-las-dan.

Sources: Catalogue of Life (COL)

Synonyms

Physalis angulata is a botanical species characterized by a complex web of taxonomic synonyms. Scientific literature identifies this plant under the alternative name Boberella angulata. Furthermore, its morphological diversity is reflected in several recognized forms, such as Physalis angulata f. linkiana and Physalis angulata f. ramosissima. The species also encompasses the variations Physalis angulata f. tenuis and Physalis angulata var. capsicifolia. Understanding these various designations is essential for accurate botanical classification and study.

Sources: The World Checklist of Vascular Plants (WCVP)

Taxonomy

Physalis angulata is a fascinating member of the kingdom Plantae. Within this vast botanical realm, the plant is classified under the class Equisetopsida. It specifically belongs to the order Solanales, showcasing its evolutionary lineage. Further taxonomic refinement places the species within the genus Physalis. Ultimately, this plant is a distinguished representative of the Solanaceae family.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Solanales
Family Solanaceae
Genus Physalis

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Physalis angulata exhibits a broad and diverse distribution across the African continent. Its presence is notable in East Tropical Africa, specifically within the borders of Tanzania. The species also extends to the Macaronesia region, finding a foothold in Cape Verde. In Northeast Tropical Africa, the plant is established in various territories including Chad, Djibouti, and Ethiopia. This wide geographical range highlights the adaptability of the species across different African climates.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Physalis angulata is a versatile herb characterized by its sturdy, self-supporting growth form. This plant typically reaches a maximum height of 3 meters, allowing it to stand prominently in its environment. While its height can vary significantly, it rarely stays below a minimum threshold of 0.525 meters. In some instances, the growth may start from a base of 0 meters as it establishes itself in the soil. These varying dimensions highlight the adaptable nature of this botanical species.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Physalis angulata is a medicinal herb that demonstrates a diverse range of potent pharmacological activities. Scientific research highlights its significant antimalarial and antiplasmodial properties, making it a promising candidate for overcoming drug resistance in malaria treatment. Furthermore, the plant exhibits strong antioxidant capabilities, which are attributed to the presence of bioactive compounds like α-tocopherol. Its cytotoxic effects have also been extensively studied, specifically through the discovery of withanolides that target various cell lines. These combined attributes, including its potential anticancer activity, position Physalis angulata as a vital resource for future drug development and therapeutic research.

Compounds

Physalis angulata is a medicinal plant recognized for its rich profile of bioactive secondary metabolites. Research indicates that this species contains a variety of significant compounds, including withanolides and flavonoids. Furthermore, the plant is a known source of chlorogenic acid, which contributes to its complex chemical makeup. Detailed metabolomic studies have also confirmed the presence of physalins within its tissues. Among these specialized steroid derivatives, specific constituents such as physalin F play a key role in its pharmacological potential.

Conditions

Physalis angulata demonstrates significant medicinal value through its ability to treat malaria, as evidenced by its role in herbal decoctions that eliminate parasites from the blood. Scientific reviews and studies further confirm that the plant possesses potent anticancer properties, particularly through its bioactive withanolide derivatives. Its anti-inflammatory effects are well-documented, often functioning by inhibiting nitric oxide (NO) production in stimulated cells. Additionally, the plant serves as an effective antibacterial agent, contributing to its wide range of therapeutic applications. These diverse biological activities highlight Physalis angulata as a promising candidate for various pharmacological treatments.

Preparations

Physalis angulata is prepared as whole plants, extracts, and crude extracts according to various research contexts. The plant is also utilized in the form of extracts to develop pharmaceutical compositions with antileishmanial, antimalarial, or trypanocidal activity. Additionally, studies indicate that Physalis angulata is prepared as extracts for diverse therapeutic patent applications. Documentation of preparation methods also shows that Physalis angulata is prepared as a decoction in some medicinal contexts.

Parts used

Physalis angulata is a versatile medicinal plant whose various morphological parts offer significant pharmacological potential. Scientific investigations have identified bioactive withanolide derivatives within its leaves and fruits, showcasing promising antiproliferative and anticancer activities. The plant's flowers have also been studied for their impact on antioxidant enzyme activity and cholesterol levels in biological models. Furthermore, extracts from the root have been evaluated as strong candidates for cancer prevention due to their rich profile of diverse phytocompounds. Collectively, these studies highlight how the leaves, fruits, flowers, and roots of this species contribute to its diverse therapeutic applications.